SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jenburkt Pharma - Quaterly Results

07 Nov 2023 Evaluate
A fair growth of 6.80% in the revenue at Rs. 382.89 millions was reported in the September 2023 quarter as compared to Rs. 358.52 millions during year-ago period.Modest increase of 6.64% in the Net Profit was reported from. 68.66 millions to Rs. 73.22  millions.Operating profit for the quarter ended September 2023 rose to 102.00 millions as compared to 98.78 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 382.89 358.52 6.80 674.64 669.84 0.72 1367.49 1239.80 10.30
Other Income 10.96 12.61 -13.08 21.33 24.04 -11.27 51.23 49.49 3.52
PBIDT 102.00 98.78 3.26 182.05 182.93 -0.48 354.90 322.04 10.20
Interest 0.69 0.94 -26.60 1.43 1.81 -20.99 3.67 4.35 -15.63
PBDT 101.31 97.84 3.55 180.62 181.12 -0.28 351.23 317.69 10.56
Depreciation 5.91 5.45 8.44 10.91 10.80 1.02 22.59 18.99 18.96
PBT 95.40 92.39 3.26 169.71 170.32 -0.36 328.64 298.70 10.02
TAX 22.18 23.73 -6.53 42.79 42.13 1.57 82.58 75.74 9.03
Deferred Tax -3.48 -1.27 174.02 -2.89 -2.10 37.62 -2.25 2.96 -176.01
PAT 73.22 68.66 6.64 126.92 128.19 -0.99 246.06 222.96 10.36
Equity 44.13 45.89 -3.84 44.13 45.89 -3.84 44.13 45.89 -3.84
PBIDTM(%) 26.64 27.55 -3.31 26.98 27.31 -1.19 25.95 25.98 -0.09

Jenburkt Pharma Share Price

1052.75 2.35 (0.22%)
21-Apr-2026 11:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.00
Dr. Reddys Lab 1222.65
Cipla 1229.95
Zydus Lifesciences 931.80
Lupin 2323.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×